참여증명서 발급문의하기사이트맵

임상시험 참여 임상시험이란 임상시험 동향 기업상담센터 국가감염병임상시험센터 임상시험 교육 알림·참여

임상시험 동향

코로나19 임상시험 현황

ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.

전체 2310건의 자료가 검색되었습니다.

Excel Download 전체화면

코로나19(COVID19) 임상시험 현황
No. Status Study Title Conditions Interventions Phase Sponsor/Collaborators Funder Type Number Enrolled Sex Age Locations
1547 Completed Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients Covid-19 Drug: Antroquinonol
Other: Placebo
Phase 2 Golden Biotechnology Corporation INDUSTRY 124 All 18 Years ~ 80 Years Franciscan Health Michigan City, Michigan City, Indiana, United States
Ascension.Via Christi Research, Wichita, Kansas, United States
Adventist Healthcare Shady Grove Medical Center, Rockville, Maryland, United States
South Jersey Infectious Disease, Somers Point, New Jersey, United States
Duke University Southeastern Health, Lumberton, North Carolina, United States
Centro Gallego, Buenos Aires, Capital Federal, Argentina
Clinica de los Virreyes, Buenos Aires, Capital Federal, Argentina
Sanatorio Privado Mayo SA, Cordoba, Ciudad De Cordoba, Argentina
Hospital Rawson, Cordoba, Cuidad De Cordoba, Argentina
Clinica Viedma SA, Viedma, Pcia De Rio Negro, Argentina
Clinica Internacional S.A. - Sede Lima, Lima Cercado, Lima, Peru
Unidad de Investigacion, Hospital Nacional IV Alberto Sabogal Sologuren-Essalud, Red Assitencial Sabogal, Callao, Peru
Hospital de Chancay, Chancay, Peru
Asociacion Civil Selva Amazonica, Iquitos, Peru
Hospital III Daniel Alcides Carrion - EsSalud, Tacna, Peru
1546 Completed Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects Pneumonia, Viral Drug: Fostamatinib
Drug: Placebo
Phase 3 Rigel Pharmaceuticals INDUSTRY 280 All 18 Years ~ 100 Years University of California Irvine, Orange, California, United States
George Washington University Hospital, Washington, District of Columbia, United States
Alternative Research Associates, LLC, Hialeah, Florida, United States
Alternative Research Associates, LLC, Miami, Florida, United States
Loyola University Medical School, Maywood, Illinois, United States
Harvard Medical School- Bringham and Women's Hospital, Boston, Massachusetts, United States
Henry Ford, Detroit, Michigan, United States
Ascension Medical Group- St. John Clinic Infectious Disease, Tulsa, Oklahoma, United States
Houston Methodist Research Institute, Houston, Texas, United States
Clinica Chutro, Cordoba, CP, Argentina
Hospital Lencinas, Godoy Cruz, Mendoza, Argentina
Corporacion Medica de General San Martin, San Martin, Provincia De Buenos Aires, Argentina
Hospital de Alta Complejidad Cuenta Alta, Buenos Aires, Argentina
Hospital Del Bicentenario - Dr. Luis Federico Leloir, Buenos Aires, Argentina
Clinica Zabala, Buenos Aires, Argentina
Clinica Adventista Belgrano, Buenos Aires, Argentina
Clinica Monte Grande, Buenos Aires, Argentina
Hospital de Infecciosas Dr.Francisco Javier Muniz, Buenos Aires, Argentina
Sanatorio Guemes, Buenos Aires, Argentina
Sanatorio Sagrado Corazon, Buenos Aires, Argentina
Hospital San Roque, Cordoba, Argentina
Sanatorio Mayo Privado, Cordoba, Argentina
Hospital das Clinicas da Universidade Federal de Goias (HC/UFG), Goiania, Goias, Brazil
Hospital Luxenburgo-Associacao Mario Penna, Belo Horizonte, Minas Gerais, Brazil
Hospital Universitario de Maringa, Maringa, Parana, Brazil
Hosp. Angelina Caron, Campina Grande do Sul, Parana, Brazil
Irmandade da Santa Casa de Misericordia de Porto Alegre - ISCMPA, Porto Alegre, Rio Grande Do Sul, Brazil
Hospital des clinicas de porto alegre - Centro de pequisas clinicas, Porto Alegre,, RS, Brazil
Complexo de Prevencao, Diagnostico, Terapia e Reabilitacao Respiratoria LTDA, Blumenau, Santa Catarina, Brazil
Hospital Alemao Oswaldo Cruz (HAOC), Bela Vista, Sao Paolo, Brazil
Pontificia Universidade Catolica de Campinas (PUC-CAMP) - Hospital e Maternidade Celso Pierro (HMCP), Campinas, Sao Paolo, Brazil
Hospital Bandeirantes (LeForte), Liberdade, Sao Paolo, Brazil
Hospital Universitario Sao Francisco na Providencia de Deus, Braganca Paulista, Sao Paulo, Brazil
Clinica de Alergia Martti Antila S/S Ltda, Sorocaba, Sao Paulo, Brazil
Fundacao Faculdade Reg. de Med de SJRP, Sao Jose Do Rio Preto, Sao Paulo, Brazil
Star Medica Vivo Bicentenario, Nezahualcoyotl, Mex, Mexico
Unidad Medica para la Salud Integral (UMSI), Monterrey, Nuevo Leon, Mexico
Kohler & Milstein Research, Merida, Yucatan, Mexico
Hospital Cardiologica Aguascalientes, Aguascalientes, Mexico
Icaro Investigaciones en Medicina, Chihuahua, Mexico
Nuevo Hospital Civil de Guadalajara, Guadalajara, Mexico
Centro Medico Issemym Toluca, Metepec, Mexico
The American British Cowdray Medical Center I.A.P., Mexico City, Mexico
Hospital Angeles Roma, Mexico, Mexico
CEPREP Centro de Prevencion y Rehabilitacion de Enfermedades Pulmonares Cronicas, Nuevo Leon, Mexico
Hospital Civil de Culiacan, Sinaloa, Mexico
Hospital Civil de Culiacan, Sinaloa, Mexico
1545 Completed Dual MRI for Cardiopulmonary COVID-19 Long Haulers Covid19 Drug: Hyperpolarized 129Xenon gas Phase 2 Bastiaan Driehuys OTHER 18 All 18 Years Duke Asthma, Allergy, and Airway Center, Durham, North Carolina, United States
1544 Unknown status Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19 COVID-19 Drug: Interferon beta-1b
Drug: Clofazimine
Phase 2 The University of Hong Kong OTHER 81 All 18 Years The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong, China
1543 Completed Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19) COVID-19 Drug: Duvelisib
Drug: Placebo
Phase 2 Emory University, Verastem, Inc. OTHER 47 All 18 Years Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
Emory University Hospital Midtown, Atlanta, Georgia, United States
Emory University Hospital, Atlanta, Georgia, United States
1542 Completed Duvelisib to Combat COVID-19 COVID-19 Drug: Duvelisib
Procedure: Peripheral blood draw
Drug: Placebo
Phase 2 Washington University School of Medicine, Verastem, Inc. OTHER 28 All 18 Years Washington University School of Medicine, Saint Louis, Missouri, United States
1541 Withdrawn DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19) COVID19 Drug: Doxycycline
Drug: Placebo
Phase 3 Nantes University Hospital OTHER 0 All 46 Years CHU Avicenne - APHP, Bobigny, France
CHU Bordeaux, Bordeaux, France
CHU Caen, Caen, France
CHU Dijon, Dijon, France
CHU Grenoble, Grenoble, France
CHU Nantes, Nantes, France